HNGZY (Hangzhou Tigermed Consulting Co) PB Ratio: 1.26 (As of Jul. 21, 2026) — 80% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HNGZY Hangzhou Tigermed Consulting Co Ltd HNGZY
92 GF Score
Price $4.45
GF Value $5.56
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co PB Ratio?

Hangzhou Tigermed Consulting Co HNGZY 92 PB Ratio is 1.26 as of Jul. 21, 2026, which is 80% below its 10-year median of 6.38. GuruFocus rates HNGZY with a GF Score™ of 92/100 and a GF Value™ of $5.56 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Hangzhou Tigermed Consulting Co ranks worse than 51.79% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-21), Hangzhou Tigermed Consulting Co's share price is $4.45. Hangzhou Tigermed Consulting Co's Book Value per Share for the quarter that ended in Mar. 2026 was $3.53. Hence, Hangzhou Tigermed Consulting Co's PB Ratio of today is 1.26.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's PB Ratio or its related term are showing as below:

HNGZY' s PB Ratio Range Over the Past 10 Years
Min: 1.6   Med: 6.38   Max: 16.96
Current: 2.07

During the past 13 years, Hangzhou Tigermed Consulting Co's highest PB Ratio was 16.96. The lowest was 1.60. And the median was 6.38.

HNGZY's PB Ratio is ranked worse than
51.79% of 195 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96 vs HNGZY: 2.07

During the past 12 months, Hangzhou Tigermed Consulting Co's average Book Value Per Share Growth Rate was 1.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 2.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 5.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 36.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hangzhou Tigermed Consulting Co was 109.00% per year. The lowest was 2.70% per year. And the median was 35.20% per year.

Back to Basics: PB Ratio


Hangzhou Tigermed Consulting Co  (OTCPK:HNGZY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Hangzhou Tigermed Consulting Co PB Ratio Related Terms


Hangzhou Tigermed Consulting Co PB Ratio Historical Data

* Premium members only.

The historical data trend for Hangzhou Tigermed Consulting Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co PB Ratio Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.57 1.24 1.22 1.16

Hangzhou Tigermed Consulting Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.22 1.20 1.16 1.16 1.13

HNGZY vs TMO, DHR, IDXX: PB Ratio Comparison

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's PB Ratio falls into.


HNGZY
92GF Score
Hangzhou Tigermed Consulting Co Ltd HNGZY
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Tigermed Consulting Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Hangzhou Tigermed Consulting Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=4.45/3.525
=1.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 1.26 mean?
Hangzhou Tigermed Consulting Co (HNGZY) has a PB Ratio of 1.26 as of Jul. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hangzhou Tigermed Consulting Co and its competitors. This is 80% below median its historical median of 6.38. Over the past decade, Hangzhou Tigermed Consulting Co's PB Ratio has ranged from 1.60 to 16.96. According to the industry distribution chart, Hangzhou Tigermed Consulting Co ranks #101 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 51.8%.
Is Hangzhou Tigermed Consulting Co's PB Ratio too high?
Hangzhou Tigermed Consulting Co's current PB Ratio of 1.26 is 80% below median its 10-year median of 6.38. Over the past 10 years, this metric has ranged from a low of 1.60 to a high of 16.96. The Medical Diagnostics & Research industry median PB Ratio is 1.96. Hangzhou Tigermed Consulting Co's value of 1.26 is 35.7% below this industry median. Based on the distribution chart, Hangzhou Tigermed Consulting Co ranks #101 out of 195 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Hangzhou Tigermed Consulting Co ranks #101 out of 195 companies for PB Ratio. This places Hangzhou Tigermed Consulting Co in the lower half of its industry. The industry median PB Ratio is 1.96. Hangzhou Tigermed Consulting Co's value of 1.26 is 35.7% below this benchmark. Historically, Hangzhou Tigermed Consulting Co's own PB Ratio has ranged from 1.60 to 16.96 over the past decade. While the company's 10-year median is 6.38 vs. the industry median of 1.96, Hangzhou Tigermed Consulting Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 1.96, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Tigermed Consulting Co's current PB Ratio of 1.26 is 35.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hangzhou Tigermed Consulting Co and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Tigermed Consulting Co's current PB Ratio is 1.26, which is 80% below median its own 10-year median of 6.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (HNGZY) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.56, compared to a current price of $4.45 — trading 20% below its estimated fair value. The current PB Ratio is 1.26, which is 80% below median its 10-year median of 6.38 and 35.7% below the Medical Diagnostics & Research industry median of 1.96. Hangzhou Tigermed Consulting Co's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (HNGZY), the current PB Ratio is 1.26 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou Tigermed Consulting Co (HNGZY) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of $4.45 is trading 20% below its estimated GF Value™ of $5.56. GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.

Key valuation signals for HNGZY:

  • PB Ratio: 1.26 (80% below median its 10-year median of 6.38)
  • GF Value™: $5.56 vs. price of $4.45 (20% below fair value)
  • GF Score™: 92/100 with 5 warning signs
  • Industry Position: 35.7% below the Medical Diagnostics & Research median (#101 of 195)

No single metric tells the full story. See the HNGZY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou Tigermed Consulting Co Business Description

Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
92GF Score

Get the complete analysis for HNGZY

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.45
Price
$5.56
GF Value